Corporate News

Dutch Newspaper on Advanced Research, sponsored by Sensius

The Dutch newspaper AD published a keynote article on advancements in heat treatment of cancer. Daniel Deenen, one of the ...
Read More

Prof. Coen Rasch Joins Advisory Board Sensius

Sensius is proud to announce Prof.Dr. Coen Rasch as a member of its Advisory Board. Coen is a radiation oncologist ...
Read More

Sensius Appoints Rik Kielman as Marketing and Sales Director

Sensius has appointed Rik Kielman as Marketing and Sales Director. Rik studied Business Management in Groningen, the Netherlands. After his ...
Read More

Sensius unveils new applicator design

Warsaw, 22 May 2019 Using novel technology, developed by Erasmus MC and TU-Delft, Sensius has redesigned the Head and Neck ...
Read More

Erasmus MC and Sensius sign license agreement on innovative bolus technology

Prof. Gerard van Rhoon, Paul van den Biggelaar and Prof. Pieter Sonneveld Prof. P. Sonneveld, chair of the department of ...
Read More

WBAF 2019 Hears Proposition Sensius First

At the World Business Angels Investment Forum 2019 in Istanbul, Turkey (19-20 February 2019), Sensius is the first company to ...
Read More

Germany adds Hyperthermia to Treatment of Sarcomas in Certification Pilot

The most recent questionnaire for sarcoma centers as published by the DKG, the German Cancer Society, now includes the requirement ...
Read More

Maarten Paulides appointed Scientific Director C3TE TU-Eindhoven

The Technical University Eindhoven has appointed Maarten Paulides, co-founder of Sensius, to be the new scientific director of the Center ...
Read More
Sensius: First joint EBAN Scaleup of the month May-2018

Sensius: First joint EBAN Scaleup of the month May-2018

31 May 2018 On May 31, 2018 the European Business Angels Network (EBAN) and the European Agency for Small and ...
Read More
2nd Annual ESHO Sensius Young Investigators Award

2nd Annual ESHO Sensius Young Investigators Award

19 May, 2018 Sensius is sponsor of the European Society for Hyperthermic Oncology (ESHO). During the annual conference in May ...
Read More
New! Advisory Board Sensius

New! Advisory Board Sensius

1 May, 2018 In May 2018 Sensius established an Advisory Board with board members with specific knowledge and experience on ...
Read More
Interview Life Sciences & Health 010 magazine

Interview Life Sciences & Health 010 magazine

February 2018 In December 2017 our CEO Paul van den Biggelaar was interviewed by the Life Sciences & Health 010 ...
Read More

Pitch during Innovation for Health

Februari 2018 In February 2018 Sensius was invited for a pitch among other Dutch innovative startups during the congress Innovation ...
Read More

“High Interest from key opinion leaders to implement HyperCollar3D for Re-radiation of H&N Cancer”

Rotterdam, 24 December 2017 MedValue: “High Interest from key opinion leaders to implement HyperCollar3D for Re-radiation of H&N Cancer” The ...
Read More

Sarah Brueningk receives Sensius Award at ESHO2017

At ESHO2017 in Athens, Sarah Brueningk received the Sensius Young Investigator Award for her presentation "Simulating response to multimodality therapies ...
Read More

Swiss reimburse hyperthermia treatments

Aarau, 1 January 2017 Swiss health authorities have decided to include treatment of cancer through a combination of radiotherapy and ...
Read More

Sensius contributes to control of cost of health care

Den Haag, 1 December 2016 Dutch Cancer Foundation (KWF) has collected 18 innovative ideas to keep cancer treatments economically accessible ...
Read More

Sensius: “Hyperthermia for H&N can be introduced without additional cost”

Amersfoort, 27 june 2016 At a special event of KWF Kankerbestrijding (DCI) on Business Models for the Future, Sensius presented ...
Read More

Erasmus MC reveals promising early clinical results on HYPERcollar3D

Rotterdam, 15 september 2015 At ESHO 2015 in Zurich, Netteke van Holthe shared early experience with the HYPERcollar3D applicator as ...
Read More

Spin off: Collaboration Erasmus MC and Sensius

Rotterdam, 10 april 2015 Erasmus MC Cancer Institute and Sensius BV have signed an agreement to collaborate on the advancement ...
Read More

Comments are closed.